Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Interim Results

25 Jan 2019 10:16

RNS Number : 1397O
Marechale Capital PLC
25 January 2019
Β 

25 January 2019

Β 

Marechale Capital plc

("Marechale Capital" or the "Company")

Β 

Interim Results

Β 

Marechale Capital plc today announces its unaudited interim results for the six months ended 31 October 2018.

Β 

Chairman's Statement

Β 

I report poor operating results for the first half which are broadly in line with the same period last year: revenues of Β£136,000 (2017: Β£125,000); and an operating loss of Β£(251,000) (2017 Β£(279,000)). The Company's net loss of Β£(184,000) (2017: Β£(460,000)) is after taking into account a gain of Β£67,000 on the realisation of one investment and in 2017, making a provision against the fair value of options held in investee companies of Β£119,000 and a provision for project loss in an associate of Β£63,000. Whilst our current deal flow remains strong, a number of the transactions we are involved in are taking longer to complete.

Β 

Marechale Capital is highly selective about the management teams, as well as the companies, it advises and backs with its investor relationships. On a more positive note this long-term strategy has resulted inΒ 2018 being the Company's best year for exits with 5 multiple investor return exits and one write-off. Successful exits include the Sheen Falls Lodge, West Country Renewables and Inn Collection and more details on these, and the other transactions, can be found on our website.

Β 

The Board of Marechale Capital continues to consider its options and its future strategy.

Β 

Β 

Mark Warde-Norbury

Chairman

Β 

Β 

Β 

For further information please contact:

Β 

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

Β 

Tel: +44 (0)20 7628 5582

Cenkos Securities

Azhic Basirov / David Jones

Tel: +44 (0)20 7397 8900

Β 

Β 

Β 

Consolidated Income Statement (unaudited)

Β 

Β 

6 months ended

Β 

Β 

Β 

Β 

31 October

31 October

Β 

Β 

Β 

Β 

Β 

2018

2017

Β 

Β 

Β 

Β 

Β 

Β£

Β£

Revenue

Β 

Β 

Β 

Β 

136,491

125,066

Cost of sales

Β 

Β 

Β 

Β 

(61,611)

(44,370)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Gross profit

Β 

Β 

Β 

Β 

74,880

80,696

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Administrative expenses

Β 

Β 

Β 

(325,927)

(358,988)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Operating (loss)

Β 

Β 

Β 

(251,047)

(278,291)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Investment revenues

Β 

Β 

Β 

67,389

-

Other (losses)

Provision for project loss in associate

Β 

Β 

Β 

-

(118,5000)

(63,000)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(Loss) before tax

Β 

Β 

Β 

(183,658)

(459,791)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Taxation

Β 

Β 

Β 

Β 

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(Loss) for the period

Β 

(183,658)

(459,791)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(Loss) per share

Β 

Β 

Β 

(Pence)

(Pence)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

- Basic

Β 

(0.32)

(0.69)

Β 

- Diluted

Β 

Β 

Β 

(0.32)

(0.69)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Consolidated Balance Sheet (unaudited)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

As at

Β 

Β 

Β 

Β 

31 October

31 October

Β 

Β 

Β 

Β 

Β 

Β 

2018

2017

Β 

Β 

Β 

Β 

Β 

Β 

Β£

Β£

Β 

Non current assets

Β 

Β 

Β 

Β 

Β 

Β 

Investment in associate

Β 

Β 

Β 

14,038

14,187

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Current assets

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Available for sale investments

Β 

Β 

107,087

153,341

Β 

Trading investments

Β 

Β 

Β 

78,388

78,388

Β 

Trade and other receivables

Β 

Β 

80,485

69,894

Β 

Cash and cash equivalents

Β 

Β 

63,172

98,110

Β 

Β 

Β 

Β 

Β 

Β 

329,132

399,734

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total assets

Β 

Β 

Β 

Β 

343,170

413,921

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Current liabilities

Β 

Β 

Β 

Β 

Β 

Β 

Trade and other payables

Β 

Β 

Β 

(117,107)

(125,596)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total current liabilities

Β 

Β 

Β 

(117,107)

(125,596)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net assets

Β 

Β 

Β 

Β 

226,063

288,325

Β 

Β 

Equity

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Capital and reserves attributable to equity shareholders

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Share capital

Β 

Β 

Β 

Β 

461,449

461,449

Β 

Revaluation reserve

Β 

Β 

Β 

25,826

81,826

Β 

Reserve for own shares

Β 

Β 

Β 

(50,254)

(50,254)

Β 

Retained losses

Β 

Β 

Β 

(210,958)

(289,150)

Β 

Reserve for share based payments

Β 

Β 

Β 

-

84,453

Β 

Β 

Β 

Β 

Β 

Β 

226,063

288,325

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Consolidated Cash Flow Statement (unaudited)

Β 

Β 

Β 

Β 

Β 

Β 

6 months ended

31 October

31 October

Β 

Β 

Β 

Β 

Β 

2018

2017

Β 

Β 

Β 

Β 

Β 

Β£

Β£

Net cash from operating activities

Β 

Β 

Β 

Β 

Operating loss

Β 

(251,047)

(278,291)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Operating cash flows before movements in working capital

(251,047)

(278,291)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Movement in working capital

Β 

Β 

Β 

Β 

Decrease in receivables

Β 

Β 

120,689

151,781

(Decrease) in payables

Β 

Β 

(4,239)

(77,755)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

116,450

74,026

Β 

Β 

Β 

Β 

Β 

Β 

Operating cash flow

Β 

Β 

Β 

(134,597)

(204,265)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Investment activities

Β 

Β 

Β 

Β 

Β 

Proceeds on disposal of available for sale investments

91,529

-

Expenditure on available for sale investments

Other

Β 

(12,700)

600

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flow from investing activities

Β 

Β 

79,429

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Financing

Β 

Β 

Β 

Β 

Β 

Β 

Issue of share capital

Β 

Β 

Β 

-

-

Interest payable

Β 

Β 

Β 

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flow from financing activities

Β 

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net decrease) in cash and cash equivalents

Β 

(55,168)

(204,265)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents at start of the period

118,340

302,375

Cash and cash equivalents at end of the period

63,172

98,110

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(Decrease) in cash and cash equivalents

Β 

(55,168)

(204,265)

Β 

Β 

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
IR CKPDKKBKDDDB
Date   Source Headline
6th Nov 20151:24 pmRNSNorthfield UK Solar Update
17th Sep 20154:14 pmRNSResult of AGM
26th Aug 20153:23 pmRNSPosting of Annual Report and Notice of AGM
26th Aug 20158:12 amRNSNorthfield UK Solar Update
24th Aug 20154:04 pmRNSHolding(s) in Company
21st Aug 201511:03 amRNSShare Price Movement
28th Jul 20151:41 pmRNSFinal Results
3rd Jun 20154:30 pmRNSHolding(s) in Company
5th May 20155:03 pmRNSDirector/PDMR Shareholding
2nd Apr 20159:45 amRNSHolding(s) in Company
31st Mar 20153:16 pmRNSHolding(s) in Company
20th Feb 201512:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20152:52 pmRNSDirector/PDMR Shareholding
2nd Feb 20155:24 pmRNSDirector/PDMR Shareholding
9th Dec 20144:41 pmRNSHolding(s) in Company
24th Sep 20142:28 pmRNSResult of AGM
27th Aug 20148:25 amRNSPosting of Annual Results and Notice of AGM
11th Aug 201410:13 amRNSHolding(s) in Company
25th Jul 201410:13 amRNSFinal Results
11th Apr 20142:33 pmRNSHolding(s) in Company
11th Apr 20148:55 amRNSDirector/PDMR Shareholding
8th Apr 20145:20 pmRNSHolding(s) in Company
18th Mar 20143:12 pmRNSHolding(s) in Company
17th Feb 20142:26 pmRNSCompletes Solar Funding Round
18th Dec 20132:37 pmRNSDirector/PDMR Shareholding
17th Dec 20137:00 amRNSInterim Results
9th Dec 20135:06 pmRNSHolding(s) in Company
17th Oct 201311:26 amRNSHolding(s) in Company
10th Oct 20132:42 pmRNSDirector/PDMR Shareholding
18th Sep 20132:12 pmRNSResult of AGM
3rd Sep 20131:45 pmRNSDirector/PDMR Shareholding
8th Aug 201311:34 amRNSPosting of Results & Notice of AGM
1st Aug 20132:13 pmRNSDirector/PDMR Shareholding
25th Jul 20134:41 pmRNSHolding(s) in Company
25th Jul 20137:00 amRNSFinal Results
26th Jun 20137:00 amRNSBoard change
3rd Apr 201310:58 amRNSDirector/PDMR Shareholding
30th Jan 20135:47 pmRNSHolding(s) in Company
13th Dec 20127:00 amRNSHalf Yearly Report
25th Sep 20123:53 pmRNSResult of AGM
17th Sep 20124:26 pmRNSPosting of Annual Report & Notice of AGM
4th Sep 20125:49 pmRNSHolding(s) in Company
4th Sep 20125:48 pmRNSHolding(s) in Company
15th Aug 20124:00 pmRNSFinal Results
18th Apr 201212:06 pmRNSDirector/PDMR Shareholding
22nd Mar 20122:53 pmRNSHolding(s) in Company
21st Feb 20123:58 pmRNSHolding(s) in Company
21st Feb 20123:54 pmRNSDirector/PDMR Shareholding
21st Dec 20117:00 amRNSHalf Yearly Report
11th Nov 20113:58 pmRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.